EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Dissecting the epigenetic orchestra of HDAC isoforms in breast cancer development: a review

Maria Debbarma, Kakali Sarkar, Samir Kumar Sil

Medical Oncology · 12.11.2024 · 42 (1)

DOI: 10.1007/s12032-024-02553-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Oncology, online erschienen am 12.11.2024. Verfasst von Maria Debbarma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Genetics & Cancer Biology Laboratory, Department of Human Physiology, Tripura University, Suryamaninagar, Tripura, 799022, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Histone Deacetylases, Epigenesis, Genetic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic modulators have recently emerged as potential targets in cancer therapy. Breast cancer, the second leading cause of cancer-related deaths among women globally and the most common cancer in India, continues to have a low survival rate despite available treatments. This underscores the urgent need for more effective therapeutic strategies. Histone deacetylases (HDACs), a prominent class of epigenetic modulators, are frequently overexpressed in various cancers, including breast cancer, making them and their downstream pathways, a focus of current research, aiming to develop more effective and less invasive treatments that could help overcome chemoresistance and enhance patient outcomes. Despite the growing body of evidences, a comprehensive and consolidated review on molecular intricacy behind the HDAC-mediated epigenetic regulation of breast cancer is conspicuously absent. Therefore, this review aims to open doors for future research by exploring the evolving role of HDACs, their molecular mechanisms, and their potential as therapeutic targets in breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHistone DeacetylasesEpigenesis, GeneticHumansFemaleGene Expression Regulation, NeoplasticHistone Deacetylase InhibitorsIsoenzymes

Stichwörter der Autor:innen

Breast cancerEpigeneticsEpitargetHistone deacetylasesMechanistic role

Substanzen

Histone DeacetylasesHistone Deacetylase InhibitorsIsoenzymes

Autor:innen und Institutionen

  • Molecular Genetics & Cancer Biology Laboratory, Department of Human Physiology, Tripura University, Suryamaninagar, Tripura, 799022, India.
  • Molecular Genetics & Cancer Biology Laboratory, Department of Human Physiology, Tripura University, Suryamaninagar, Tripura, 799022, India. s_k_sil@tripurauniv.ac.in.

Zitieren

APA

Debbarma, M., Sarkar, K., & Sil, S. K. (2024). Dissecting the epigenetic orchestra of HDAC isoforms in breast cancer development: a review. Medical Oncology, 42(1). https://doi.org/10.1007/s12032-024-02553-9

Vancouver

Debbarma M, Sarkar K, Sil SK. Dissecting the epigenetic orchestra of HDAC isoforms in breast cancer development: a review. Medical Oncology. 2024;42(1). doi:10.1007/s12032-024-02553-9

BibTeX
@article{Debbarma2024,
  author = {Debbarma, Maria and Sarkar, Kakali and Sil, Samir Kumar},
  title = {Dissecting the epigenetic orchestra of HDAC isoforms in breast cancer development: a review},
  journal = {Medical Oncology},
  year = {2024},
  volume = {42},
  number = {1},
  doi = {10.1007/s12032-024-02553-9}
}
Kostenlos starten →